Columbus, Ohio —The Ohio State University College of Pharmacy Division of Medicinal Chemistry and Pharmacognosy and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) recently partnered to build a shared resource focused on phenotypic and target-based screening of libraries of small molecules via high-content and […]
Columbia, Missouri, USA and Utrecht, the Netherlands Harry S. Truman Memorial Veterans’ Hospital’s research program is nationally recognized, in part, because of its Biomolecular Imaging Center (BIC). Using the latest imaging technology, researchers at Truman VA’s BIC conduct preclinical and translational studies to improve the lives of Veterans and all Americans through health care discovery […]
BOSTON, Mass. — Emulate, Inc. today announced that the company has completed the 150th installation of its Zoë® instrument, part of a lab-ready platform for Organs-on-Chips technology for use by researchers across many industries, particularly with early adopters conducting R&D related to drug discovery and development. Emulate has expanded its portfolio of commercially available Zoë-compatible […]
SOUTH EASTON, Massachusetts — Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company has received a purchase order from a new customer, Can B Corp (OTC:CANBD), […]
SAN JOSE, Calif. — ForteBio, the Biologics Business Unit of Molecular Devices, today announced that to aid in the discovery of human therapeutic antibodies to viral infections like dengue fever and eastern equine encephalitis, the Vanderbilt Vaccine Center recently became one of the first academic institutes in North America to adopt ForteBio’s Octet HTX system. A centerpiece in the Biopharm […]
Genedata Profiler used for biomarker discovery and validation projects in support of Chugai’s early proof of concept research initiatives Tokyo, Japan – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Chugai Pharmaceutical Co., Ltd., a leading research-based pharmaceutical company in Japan, has chosen Genedata Profiler® as one of the […]
We are proud to announce the first sale of the Biopixlar® platform to University of Canterbury, NZ. The sale goes to Dr. Yilei Zhang who will use Biopixlar for both research and education. In addition to the sale of the platform, University of Canterbury enters into a collaboration with Fluicell to act as a demo site for […]
Berlin-Germany and Utrecht, Netherlands The Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration at the Charité – Universitätsmedizin Berlin has installed a MILabs extra ultra-high resolution microCT (U-CT XUHR) system as an essential research tool to study the interplay between biology and mechanical strain. The unit will be used to to study the effects of […]
Lausanne-Switzerland and Utrecht-the Netherlands The University of Lausanne (UNIL) and the Lausanne University Hospital (CHUV) have acquired MILabs latest in-vivo optical imaging and diagnostic X-ray CT systems. The systems will be installed in the In-Vivo Imaging Facility (IVIF) and serve a dual optical imaging function. Aptly named the Duet Optical Imaging Module, the system can […]
NANJING, China and EMERYVILLE, Calif. — GenScript Biotech Corp., the world’s leading pharmaceutical CDMO company, announced today that the company is adopting a state-of-the-art optofluidic single-cell platform known as the Beacon® platform. The platform was developed by Berkeley Lights, Inc., a company committed to helping customers find the best cells to accelerate the use of cell-based products. […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
